RESTRUCTURING OF INTERESTS IN MEDICLINIC HOLDINGS IMPLEMENTATION OF TRANSACTION
Capitalised terms used in this announcement shall, unless otherwise defined herein or the context otherwise requires, have the same meanings as set out in Remgro's category 2 announcement dated 31 March 2026 ("Category 2 Announcement").
01 July 2026
Read AnnouncementINTERIM RESULTS 2025
Interim Report Unaudited Results for the six months ended 31 December 2025 and cash dividend declaration
ANNUAL REPORT 2025
Our report reflects our stakeholders' interests, our role as a responsible steward of our investee companies and the information needs of our capital providers.
ESG AND SUSTAINABILITY REPORT
Remgro’s long-term sustainability ambitions are underpinned by a specific focus on material environmental and social issues, including risk management and governance.
Established in the 1940s by Dr Anton Rupert as a tobacco company, Remgro has evolved into a highly diversified investment holding company. Our interests fall mainly in the healthcare, consumer products, financial services, infrastructure and industrial sectors.
Remgro invests in reputable businesses that are aligned with its values and purpose, with sound management teams that have the potential to deliver superior earnings, sustainable cash flow generation and dividend growth over the long term.
as at 31 December 2025
Headline earnings per share
931 cents
(up by 38.5%)
Interim dividend per share
173 cents
(up by 80.2%)
Intrinsic net asset value per share
R297.03
(up by 1.6%) since 30 June 2025
As Remgro's portfolio evolves towards more unlisted exposure, our management philosophy has become more dynamic, adapting to the requirements of investee companies.
as at 30 June 2026
Remgro's healthcare portfolio comprises its restructured interests in Mediclinic, a leading international healthcare group with a more than four-decade heritage in Southern Africa. Following the implementation of the restructuring on 1 July 2026, Remgro owns 100% of Mediclinic Southern Africa and retains its 50% interest in Mediclinic Middle East, as well as its indirect interest in Spire Healthcare. Remgro no longer holds an interest in Hirslanden, Mediclinic's Swiss business. The investment continues to provide exposure to defensive, high-quality healthcare services, supported by strong operational performance, growing patient volumes and ongoing efficiency improvements. This sector contributes 24.4% of Remgro's net asset value.
DISCOVER SECTOR
Remgro's consumer products portfolio comprises shareholdings in RCL Foods (79.5%), Siqalo Foods (100.0%), Heineken Beverages (18.8%), Capevin (33.6%) and Rainbow (79.5%) providing exposure to the food and beverage sector and supporting sustainable earnings growth and long-term value creation. This sector comprises 15.5% of Remgro's net asset value.
Remgro's financial services portfolio includes shareholdings in OUTsurance (30.5%) and Business Partners (45.0%). These investments provide diversified exposure across the sector and underpin sustainable earnings growth and long-term value creation. This sector contributes 20.6% to Remgro's net asset value.
Remgro's industrial portfolio includes shareholdings in Air Products (50.0%), TotalEnergies (24.9%), and Wispeco (100%). These investments offer diversified exposure across the industrial sector and support sustainable earnings growth and long-term value creation. This sector contributes 7.4% to Remgro's net asset value.
Remgro's infrastructure portfolio comprises shareholdings in Community Investment Ventures Holdings (57.0%), SEACOM (30.0%) and Ubiquity Energy (75.0%). These investments provide diversified sector exposure and support sustainable earnings growth and long-term value creation. This sector comprises 10% of Remgro's net asset value.
Remgro's diversified investment vehicles portfolio comprises shareholdings in KTH (43.5%), Prescient, Invenfin (100.0%), ASIA Partners (6.5% Fund I, 10.0% Fund II) and Pembani Remgro Infrastructure Funds (16.2% Fund I, 24.6% Fund II). These investments offer diversified exposure across the diversified investment vehicles sector and support sustainable earnings growth and long-term value creation.
Remgro's social impact investment portfolio includes shareholdings in the Blue Bulls (50.0%), Stellenbosch Academy of Sport (100%), Stellenbosch Football Club (100%) and the Boland Cavaliers (50.0%). These investments advance community development and sporting excellence while contributing to sustainable value creation.
Remgro's central treasury and net corporate assets pillars are inter alia responsible for Remgro's central treasury function, as well as management and support services. These pillars include wholly owned interests in Remgro Finance Corporation, Remgro Healthcare Holdings, Remgro USA ‑ Jersey, Remgro Management Services (FSP 30 549), and V&R Management Services‑Switzerland.
DISCOVER SECTORAccess the latest information on Remgro and explore how we're delivering on our priorities.
2026 © Remgro Limited
Ethics hotline 0800 222 536
